In kidney cancer, several associated inflammatory signaling pathways (VHL, mTOR, TNF, STAT) was proved to be dramatically associated with carcinogenesis14, and targeting vital molecules in these pathways attenuates tumor growth and progression, based on which new drugs are developed14, 21, 22, 23. Here, MTOR is linked to kidney cancer.